1 |
Zhang Q, Zhang J, Jin H, Sheng S (2013). Whole transcriptome sequencing identifies tumor-specific mutations in human oral squamous cell carcinoma. BMC Med Genomics, 6, 28.
DOI
ScienceOn
|
2 |
Trapnell C, Pachter L, Salzberg SL (2009). TopHat: discovering splice junctions with RNA-Seq. Bioinformatics, 25, 1105-11.
DOI
ScienceOn
|
3 |
Trapnell C, Williams BA, Pertea G, et al (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol, 28, 511-5.
DOI
ScienceOn
|
4 |
Wang Z, Gerstein M, Snyder M (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet, 10, 57-63.
DOI
ScienceOn
|
5 |
Marin R, Ruiz-Cabello F, Pedrinaci S, et al (2003). Analysis of HLA-E expression in human tumors. Immunogenetics, 54, 767-75.
|
6 |
Luo A, Kong J, Hu G, et al (2004). Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene, 23, 1291-9.
DOI
ScienceOn
|
7 |
Ma S, Bao JY, Kwan PS, et al (2012). Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma. Gastroenterology, 143, 675-86 e1-12.
DOI
ScienceOn
|
8 |
Maher CA, Kumar-Sinha C, Cao X, et al (2009). Transcriptome sequencing to detect gene fusions in cancer. Nature, 458, 97-101.
DOI
ScienceOn
|
9 |
Ren S, Peng Z, Mao JH, et al (2012). RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res, 22, 806-21.
DOI
|
10 |
Huang da W, Sherman BT, Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4, 44-57.
|
11 |
Futreal PA, Coin L, Marshall M, et al (2004). A census of human cancer genes. Nat Rev Cancer, 4, 177-83.
DOI
ScienceOn
|
12 |
Gibb EA, Enfield KS, Tsui IF, et al (2011). Deciphering squamous cell carcinoma using multidimensional genomic approaches. J Skin Cancer, 2011, 541405.
|
13 |
Kim D, Salzberg SL (2011). TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol, 12, R72.
DOI
|
14 |
Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74.
DOI
ScienceOn
|
15 |
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
DOI
|
16 |
Ju YS, Lee WC, Shin JY, et al (2012). A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res, 22, 436-45.
DOI
ScienceOn
|
17 |
Kren L, Slaby O, Muckova K, et al (2011). Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance? Neuropathology, 31, 129-34.
DOI
ScienceOn
|
18 |
Langmead B, Trapnell C, Pop M, Salzberg SL (2009). Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol, 10, R25.
DOI
ScienceOn
|
19 |
Le YS, Kim TE, Kim BK, et al (2002). Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancers. Exp Mol Med, 34, 18-26.
DOI
ScienceOn
|
20 |
Bandla S, Pennathur A, Luketich JD, et al (2012). Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma. Ann Thorac Surg, 93, 1101-6.
DOI
ScienceOn
|
21 |
de Kruijf EM, Sajet A, van Nes JG, et al (2010). HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol, 185, 7452-9.
DOI
|
22 |
Lin Y, Totsuka Y, He Y, et al (2013). Epidemiology of esophageal cancer in Japan and China. J Epidemiol, 23, 233-42.
DOI
|
23 |
Spaans VM, Peters AA, Fleuren GJ, Jordanova ES (2012). HLA-E expression in cervical adenocarcinomas: association with improved long-term survival. J Transl Med, 10, 184.
DOI
|